Krsnaa Diagnostics shows solid Q3 & 9M FY26 results!

9-month revenue hit 580.2 Cr (+9% YoY), EBITDA 160.0 Cr (+13%), and PAT 59.7 Cr (+5%). Q3 revenue was 181.2 Cr (+4%). Retail business is booming, with revenue up ~8x YoY for Q3, now 10% of total revenue, thanks to soaring touch points (5 to 875!). Strategic growth includes launching the 1st Apulki Healthcare Hospital (PPP cancer/cardiac care) in Pune, with 4 more hospitals approved.

Network expanded significantly: 149 CT, 41 MRI centers, and over 4,000 collection centers.

Management aims for 200+ CT/MRI centers & 5,000+ collection points from existing projects.

With EPS at 18.2 (+5%) & 15M patients served, Krsnaa continues to deliver affordable diagnostics 50-70% below market prices, proving scale with impact.